Plasma from recovered patients studied for COVID-19 pneumonia – but trial withdrawn
NCT ID NCT04333251
First seen Jan 31, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study planned to give hospitalized adults with COVID-19 pneumonia plasma from people who had recovered from the virus. The goal was to see if this plasma could reduce the need for oxygen or breathing support. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.